Sept. 30, 2020, 5:29 p.m.
Washington: The entire world is devastated by the coronavirus pandemic which has taken more than a million lives so far, but there is no COVID-19 vaccine yet.
There are 169 COVID-19 vaccine candidates all around the globe with 26 in the human trials. Out of these, coronavirus vaccine candidates like Pfizer Inc, Johnson & Johnson, AstraZeneca-Oxford University, Novavax, and Moderna are in the last stages of human trials.
Vaccine makers of Pfizer and its partner BioNTech could release data by the end of October. “Based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October,” stated Pfizer.
Reports from Moderna vaccine makers will also provide data soon after. Since Johnson & Johnson and Novavax have recently started their late-stage trials therefore it will take time to give their reports. Reports are expected to be announced in the coming months.
Meanwhile, Russia is also planning to submit its report of 42 days of monitoring its vaccine after it has announced that Russia has made the world’s first vaccine.
The food and Drug administration office head stated clearly that the vaccine makers know what they are expecting and further added that the meeting on the vaccine report will be on October 22nd, 2020.
“The companies know what we’re expecting. On October 22, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session, to discuss, in general, the development, authorization, and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting.” said Peter Marks, the head of Food and Drug administration.